These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20085110)

  • 1. Myelodysplastic syndromes (MDS): the current landscape.
    Peskin SR
    Manag Care; 2009 Nov; 18(11 Suppl 9):2-3. PubMed ID: 20085110
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries.
    Goldberg SL; Chen E; Corral M; Guo A; Mody-Patel N; Pecora AL; Laouri M
    J Clin Oncol; 2010 Jun; 28(17):2847-52. PubMed ID: 20421543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ascertainment of patients with myelodysplastic syndromes.
    Ma X; Wang R
    J Clin Oncol; 2011 Jan; 29(1):e16; author reply e17. PubMed ID: 21079144
    [No Abstract]   [Full Text] [Related]  

  • 4. Myelodysplastic syndromes: incidence and survival in the United States.
    Ma X; Does M; Raza A; Mayne ST
    Cancer; 2007 Apr; 109(8):1536-42. PubMed ID: 17345612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of patients with myelodysplastic syndromes in the Veterans Administration population.
    Komrokji RS; Matacia-Murphy GM; Al Ali NH; Beg MS; Safa MM; Rollison DE; List AF
    Leuk Res; 2010 Jan; 34(1):59-62. PubMed ID: 19368972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myelodysplastic syndromes. A retrospective analysis of 72 cases. I. Clinical symptomatology and evolution].
    Avilés A; Romero N; García LD; Gómez J; González Llavén J
    Rev Invest Clin; 1988; 40(2):161-5. PubMed ID: 3175369
    [No Abstract]   [Full Text] [Related]  

  • 7. Myelodysplastic syndromes: what a primary care physician needs to know.
    Khan AM; Komrokji RS; Haddad RY
    Dis Mon; 2010 Aug; 56(8):468-78. PubMed ID: 20800756
    [No Abstract]   [Full Text] [Related]  

  • 8. Myelodysplastic syndromes: aspects of current medical care and economic considerations in Germany.
    Gattermann N; Hofmann WK; Meessen A; Schmitz S; Tsamaloukas A; Vollmer T; Wedding U; Plesnila-Frank C; Schramm W; Berger K
    Onkologie; 2008 Sep; 31(8-9):477-84. PubMed ID: 18787357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelodysplastic syndromes: more prevalent than we know.
    Sandhu SK; Sekeres MA
    Geriatrics; 2008 Nov; 63(11):10-7. PubMed ID: 18998762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hematologist's approach to myelodysplastic syndrome.
    Fukumoto JS
    Hawaii Med J; 2008 Jun; 67(6):164-6. PubMed ID: 18678209
    [No Abstract]   [Full Text] [Related]  

  • 11. Myelodysplastic syndromes (MDS) in Central Africans.
    Mukiibi JM; Paul B
    Trop Geogr Med; 1994; 46(1):17-9. PubMed ID: 8165730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prospective clinical study of diagnosis and classification for 282 cases with primary myelodysplastic syndrome].
    Wang XQ;
    Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):546-9. PubMed ID: 17172130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High rate of uncaptured myelodysplastic syndrome cases and an improved method of case ascertainment.
    Cogle CR; Iannacone MR; Yu D; Cole AL; Imanirad I; Yan L; Mackinnon JA; List AF; Rollison DE
    Leuk Res; 2014 Jan; 38(1):71-5. PubMed ID: 24280283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Right and left shifts for age in MDS.
    Paydas S
    Leuk Res; 2010 Apr; 34(4):409-10. PubMed ID: 19783047
    [No Abstract]   [Full Text] [Related]  

  • 15. A population-based study of survival in patients with secondary myelodysplastic syndromes (MDS): impact of type and treatment of primary cancers.
    De Roos AJ; Deeg HJ; Davis S
    Cancer Causes Control; 2007 Dec; 18(10):1199-208. PubMed ID: 17823848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adult primary myelodysplastic syndromes. Report of 36 cases].
    Khalifa M; Laatiri MA; Chehata S; Rhaiem K; Gharbi O; Amama W; Ennabli S
    Tunis Med; 2003 Apr; 81(4):226-9. PubMed ID: 12848003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mixed myelodysplastic and myeloproliferative syndromes].
    Neuwirtová R; Mociková K; Jelínek J; Musilová J; Havlícek F; Adamkov M; Michalová K; Cermák J; Jonásová A; Smolíková A; Straub J; Tothová E; Voglová J; Vozobulová V; Waltrová L
    Cas Lek Cesk; 1997 Dec; 136(23):724-9. PubMed ID: 9476375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Decision analysis to determine the appropriate treatment for low-risk myelodysplastic syndromes.
    Sekeres MA; Fu AZ; Maciejewski JP; Golshayan AR; Kalaycio ME; Kattan MW
    Cancer; 2007 Mar; 109(6):1125-32. PubMed ID: 17265521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dynamic MRI of the lumbar spine for the evaluation of microcirculation during anti-angiogenetic therapy in patients with myelodysplastic syndromes].
    Scherer A; Strupp C; Wittsack HJ; Engelbrecht V; Poll LW; Reinwand U; Willers R; Germing U; Gattermann N; Haas R; Mödder U
    Rofo; 2002 Feb; 174(2):164-9. PubMed ID: 11898077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes.
    Hu Q; Dey AL; Yang Y; Shen Y; Jilani IB; Estey EH; Kantarjian HM; Giles FJ; Albitar M
    Cancer; 2004 May; 100(9):1884-91. PubMed ID: 15112269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.